ISRCTN54191675CompletedPhase 3
Study of Peri-Articular Anaesthetic for Replacement of the Knee. The clinical and cost effectiveness of peri-articular liposomal bupivacaine compared with bupivacaine hydrochloride for post-operative recovery after knee replacement surgery: A multi-centre, blinded, randomised controlled trial
niversity of Leeds0 sites533 target enrollmentStarted: November 14, 2017Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 3
- Status
- Completed
- Sponsor
- Enrollment
- 533
Study Overview
Brief Summary
2019 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/31842977 protocol (added 18/12/2019) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35385072/ (added 07/04/2022)
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •Current participant inclusion criteria as of 11/01/2019:
- •1. Unilateral primary knee replacement, including both total knee replacement (TKR) and unicompartmental knee replacement (UKR), for end-stage osteoarthritis
- •2. American Society of Anaesthesiologists (ASA) Grade I to III
- •3. Participant is willing and able to consent for themselves
- •4. Male or female, aged 18 years or above
- •5. In the Investigator’s opinion, is able and willing to comply with all trial requirements
- •Previous participant inclusion criteria as of 26/10/2018:
- •1. Unilateral primary knee replacement, including both total knee replacement (TKR) or unicompartmental knee replacement (UKR), for end stage osteoarthritis
- •2. Willing and able consent for themselves
- •3. Male or female, aged 18 years or above
- •4. In the Investigator’s opinion, is able and willing to comply with all trial requirements.
- •Previous participant inclusion criteria:
- •1. Participant is willing and able consent for themselves
- •2. Male or Female, aged 18 years or above
- •3. End stage osteoarthritis of the knee
- •4. In the Investigator’s opinion, is able and willing to comply with all trial requirements
Exclusion Criteria
- •Current participant exclusion criteria as of 11/01/2019:
- •1. Allergy or intolerance to amide-type local anaesthetics
- •2. Objective evidence of nerve damage in the affected lower limb
- •3. Rheumatoid arthritis
- •4. Any other significant disease, disorder or condition which, in the opinion of the Investigator, may either put the participants at risk because of participation in the trial, or may influence the results of the trial, or the participant’s ability to participate in the trial
- •5. Participants who have participated in another research trial involving an investigational product in the past 6 months
- •6. Participants who have significant cognitive impairment or language issues
- •7. Contra-lateral knee replacement within the trial or within 12 months prior to randomization
- •Previous participant exclusion criteria as of 26/10/2018:
- •1. American Society of Anaesthesiologists (ASA) Grade III or above
- •2. Allergy or intolerance to amide type local anaesthetics
- •3. Objective evidence of nerve damage in the affected lower limb
- •4. Rheumatoid arthritis
- •5. Any other significant disease, disorder or condition which, in the opinion of the Investigator, may either put the participants at risk because of participation in the trial, or may influence the results of the trial, or the participant’s ability to participate in the trial
- •6. Participants who have participated in another research trial involving an investigational product in the past 6 months
- •7. Participants who have significant cognitive impairment or language issues
- •8. Contra-lateral knee replacement within the trial or within 12 months prior to randomisation
- •Previous participant exclusion criteria:
- •1. American Society of Anaesthesiologists (ASA) Grade III or above
- •2. Allergy or intolerance to amide type local anaesthetics
- •3. Objective evidence of nerve damage in the affected lower limb
- •4. Rheumatoid arthritis
- •5. Any other significant disease, disorder or condition which, in the opinion of the Investigator, may either put the participants at risk because of participation in the trial, or may influence the result of the trial, or the participant’s ability to participate in the trial.
- •6. Participants who have participated in another research trial involving an investigational product in the past 6 months
- •7. Participants who have significant cognitive impairment or language issues
- •8. Contra-lateral knee replacement (If the patient is receiving staged bilateral knees, they may still participate in the trial but data will only be included from the first knee)
Investigators
Similar Trials
Completed
Phase 2
Perineural local anaesthetic catheter after major lower limb amputation feasibility trialMajor lower limb amputationCirculatory SystemISRCTN85710690Aneurin Bevan University Health Board50
Active, not recruiting
Phase 1
Trial of locally injected pain medication for post-operative recovery after knee replacement surgeryocal anaesthetic for patients undergoing knee replacement surgery for arthritisEUCTR2016-003154-32-GBniversity of Leeds500
Completed
Phase 3
Study of Peri-Articular Anaesthetic for Replacement of the KneeKnee OsteoarthritisNCT03326180University of Leeds533
Completed
Not Applicable
Study of monitoring blood concentration of local anaesthetic after a nerve block in elderly patients with hip fractureSpecialty: Anaesthesia, perioperative medicine and pain management, Primary sub-specialty: Anaesthesia, Perioperative Medicine and Pain ManagementUKCRC code/ Disease: Injuries and Accidents/ Injuries to the hip and thighSurgeryFascia Iliaca Compartment Block (FICB)ISRCTN27364035Surrey and Sussex Healthcare NHS Trust12
Completed
Not Applicable
Perioperative Analgesia for Knee ArthroplastyISRCTN60611146niversity Hospitals Coventry & Warwickshire NHS Trust (UK)264